Clinical Trial Update: Interleukin-1 Blockade in Recently Decompensated Heart Failure [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on interleukin-1 blockade for recently decompensated heart failure (Phase 2/Phase 3) completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Heart Failure | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-12-22